Cold Start Therapeutics Revenue

Biotechnology Research • San Diego, California, United States • 1-10 Employees

Cold Start Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Cold Start Therapeutics

Tom Chen

Senior Director, Head of Biology

Company overview

Headquarters	San Diego, California, United States
Website	coldstart-tx.com
NAICS	541714
Employees	1-10

About Cold Start Therapeutics

Cold Start Therapeutics enables rational, target-first hit discovery for yet-to-be liganded targets through our computational biophysics platform's ability to reveal previously invisible pocket motion. Our technology has uniquely enabled our diverse pipeline that includes a pan-mutant, wild-type sparing, beta-catenin molecule glue degrader program, Myc molecular glue degrader program, and a GLP-1R, GIPR, GCGR (triple G) small molecule agonist program.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Head

Funding Data

Cold Start Therapeutics has never raised funding before.

Frequently asked questions

Cold Start Therapeutics is located in San Diego, California, US.

Cold Start Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Cold Start Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cold Start Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Cold Start Therapeutics

Tom Chen

Senior Director, Head of Biology

4.8

40,000 users